TR199800445A2 - cdc25B geni yükselticisi, hazirlanisi ve kullanimi. - Google Patents

cdc25B geni yükselticisi, hazirlanisi ve kullanimi.

Info

Publication number
TR199800445A2
TR199800445A2 TR1998/00445A TR9800445A TR199800445A2 TR 199800445 A2 TR199800445 A2 TR 199800445A2 TR 1998/00445 A TR1998/00445 A TR 1998/00445A TR 9800445 A TR9800445 A TR 9800445A TR 199800445 A2 TR199800445 A2 TR 199800445A2
Authority
TR
Turkey
Prior art keywords
preparation
cdc25b gene
gene amplifier
cdc25b
amplifier
Prior art date
Application number
TR1998/00445A
Other languages
English (en)
Other versions
TR199800445A3 (tr
Inventor
K�Rner Kathrin
Dr. Rolf M�Ller Prof.
Dr. Hans-Harald Sedlacek Prof.
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of TR199800445A2 publication Critical patent/TR199800445A2/tr
Publication of TR199800445A3 publication Critical patent/TR199800445A3/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/007—Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Isbu bulus cdc25B geni yükselticisi, cdc25B gen yükselticilerini bulmak için bir yöntem ve bunun bir ispençiyari ürün hazirlamak üzere kullanimlari ile ilgilidir.
TR1998/00445A 1997-03-14 1998-03-12 cdc25B geni yükselticisi, hazirlanisi ve kullanimi. TR199800445A3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19710643A DE19710643A1 (de) 1997-03-14 1997-03-14 Der Promotor des cdc25B Genes und seine Verwendung in der Gentherapie

Publications (2)

Publication Number Publication Date
TR199800445A2 true TR199800445A2 (tr) 1999-04-21
TR199800445A3 TR199800445A3 (tr) 1999-04-21

Family

ID=7823404

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00445A TR199800445A3 (tr) 1997-03-14 1998-03-12 cdc25B geni yükselticisi, hazirlanisi ve kullanimi.

Country Status (13)

Country Link
US (1) US6033856A (tr)
EP (1) EP0864651A3 (tr)
JP (1) JPH11181A (tr)
KR (1) KR19980080569A (tr)
AR (1) AR011458A1 (tr)
AU (1) AU739145B2 (tr)
BR (1) BR9800913A (tr)
CA (1) CA2231917A1 (tr)
CZ (1) CZ75798A3 (tr)
DE (1) DE19710643A1 (tr)
HU (1) HUP9800574A3 (tr)
PL (1) PL325362A1 (tr)
TR (1) TR199800445A3 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19639103A1 (de) * 1996-09-24 1998-03-26 Hoechst Ag Nukleinsäurekonstrukte mit Hybridpromotoren für gentherapeutische Maßnahmen
DE19710643A1 (de) * 1997-03-14 1998-09-17 Hoechst Ag Der Promotor des cdc25B Genes und seine Verwendung in der Gentherapie
CZ121599A3 (cs) 1998-04-09 1999-10-13 Aventis Pharma Deutschland Gmbh Jednořetězcová molekula vázající několik antigenů, způsob její přípravy a léčivo obsahující tuto molekulu
DE19900743A1 (de) 1999-01-12 2000-07-13 Aventis Pharma Gmbh Neue komplexbildende Proteine
JP2003518367A (ja) * 1999-09-13 2003-06-10 ベーアーエスエフ アクツィエンゲゼルシャフト 細胞周期の変調物質をスクリーニングするための方法及び組成物
IL132446A0 (en) * 1999-10-18 2001-03-19 Genena Ltd A method for establishing connections between genes
AU2001263047A1 (en) * 2000-05-10 2001-11-20 Trustees Of Boston University Compositions and methods for treatment of proliferative disorders
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
US20030211076A1 (en) * 2001-05-10 2003-11-13 Wande Li Compositions and methods for treatment of proliferative disorders
AU2003241409A1 (en) * 2003-05-12 2005-01-21 Potomac Pharmaceuticals, Inc. Gene expression suppression agents
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
AU2005287273B2 (en) 2004-09-07 2011-05-12 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
US20070066551A1 (en) * 2004-09-07 2007-03-22 Keefe Anthony D Aptamer medicinal chemistry
UA100692C2 (ru) 2007-05-02 2013-01-25 Мериал Лимитед Днк-плазмиды, имеющие повышенную экспрессию и стабильность
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
US9719146B2 (en) * 2009-09-09 2017-08-01 General Electric Company Composition and method for imaging stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006938A1 (de) * 1994-08-26 1996-03-07 Hoechst Aktiengesellschaft Gentherapeutische behandlung von gefässerkrankungen durch einen zellspezifischen, zellzyklusabhängigen wirkstoff
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
DK0807183T3 (da) * 1994-08-26 2001-03-05 Aventis Pharma Gmbh Genterapi af sygdomme, der fremkaldes af immunsystemet, ved hjælp af et cellespecifikt aktivt stof, der reguleres af cellec
DE19710643A1 (de) * 1997-03-14 1998-09-17 Hoechst Ag Der Promotor des cdc25B Genes und seine Verwendung in der Gentherapie

Also Published As

Publication number Publication date
US6033856A (en) 2000-03-07
PL325362A1 (en) 1998-09-28
HU9800574D0 (en) 1998-05-28
EP0864651A2 (de) 1998-09-16
CA2231917A1 (en) 1998-09-14
DE19710643A1 (de) 1998-09-17
HUP9800574A3 (en) 2003-08-28
BR9800913A (pt) 1999-12-21
AU739145B2 (en) 2001-10-04
AR011458A1 (es) 2000-08-16
HUP9800574A2 (hu) 1999-03-29
EP0864651A3 (de) 2000-07-26
AU5846598A (en) 1998-09-17
KR19980080569A (ko) 1998-11-25
JPH11181A (ja) 1999-01-06
TR199800445A3 (tr) 1999-04-21
CZ75798A3 (cs) 1998-09-16

Similar Documents

Publication Publication Date Title
TR199800445A2 (tr) cdc25B geni yükselticisi, hazirlanisi ve kullanimi.
TR199800327T1 (tr) Açilaminosalisilamidler.
EE200000378A (et) Adamantaani derivaadid
EE200000320A (et) Uudsed ühendid
ES2065919T3 (es) Ribozimas.
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
IL130260A (en) 3-thiocarbamoylpyrazole derivatives as pesticides
IT7868772A0 (it) Macchina per la palettizzazione di colli e specialmente per segnature raccolte in libri non ancora cuciti, e simili
BG102945A (en) Carbamide derivatives as inhibitors of enzyme inosine-5'-monophosphate dehydrogenase
DK0493480T3 (da) Dehydrodidemnin B
TR199902383T2 (tr) Yeni pirimidin türevleri ve bunlarin hazirlanmasi için proses.
TR200000272T2 (tr) Antitümör ve antimetastaz maddeleri olarak o-ikameli hidrosikumaranon türevleri.
IT1299068B1 (it) Legandi fosforati chirali e loro complessi organometallici, utili come catalizzatori in sintesi stereoselettive
TR199801328T2 (tr) Yeni tarz benzoilguanidin-türevleri, üretim yöntemleri.
ATE175215T1 (de) Arzneimittel für die verlängerte immunsuppression und tumorzellelimination
DK0914043T3 (da) Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
MX9606584A (es) Biosensores sensibles a masas.
ATE267195T1 (de) Oxiranyl-triazolinthione und ihre verwendung als mikrobizide
DE68914278D1 (de) Heftvorrichtung für blattstapel.
DE69829880D1 (de) Konjugate enthaltend zwei wirkstoffe
DE69009449D1 (de) Turbogebläse für laser und laseroszillator, der dieses benutzt.
NO991867D0 (no) Biaromatiske forbindelser bundet via et heteroetynylenradikal, og farmas°ytiske og kosmetiske sammensetninger inneholdende dem
PT80221B (en) Improved process for preparing benzamide derivatives useful as anticonvulsant agents
BR9812498A (pt) Nucleosìdeo ligante, sua preparação e seu uso